Ara
Toplam kayıt 9, listelenen: 1-9
Is infertility a predictor of prostate cancer?
(Elsevier, 2021)
...
Current state of image-guided focal therapy for prostate cancer
(Springer, 2021)
Purpose To review the current evidence regarding protocols and outcomes of image-guided focal therapy (FT) for prostate cancer (PCa). Methods A literature search of the latest published studies assessing primary FT for PCa ...
Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
(Springer, 2021)
Objective To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a ...
Making a case "against" focal therapy for intermediate-risk prostate cancer
(Springer, 2021)
Introduction Focal therapy (FT) for localized prostate cancer (PCa) is a promising treatment strategy. Although, according to guidelines, it should be regarded as an experimental option, its introduction into clinical ...
Role of multiparametric prostate MRI in the management of prostate cancer
(Springer, 2021)
Introduction Prostate cancer has traditionally been diagnosed by an elevation in PSA or abnormal exam leading to a systematic transrectal ultrasound (TRUS)-guided biopsy. This diagnostic pathway underdiagnoses clinically ...
Tumour microenvironment and focal therapy for prostate cancer
(Lippincott Williams & Wilkins, 2022)
Purpose of review Although most studies focus on the tumour component of prostate cancer (PCa), increasing attention is being paid to the prostatic tumour microenvironment (TME) and its role in diagnosis, prognosis, and ...
Role of MRI for the detection of prostate cancer
(Springer, 2021)
The use of multiparametric MRI has been hastened under expanding, novel indications for its use in the diagnostic and management pathway of men with prostate cancer. This has helped drive a large body of the literature ...
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: Current perspective and ongoing trials
(Springer, 2021)
Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there ...
HRM method for identification of TP53 exon 5 and 8 mutations in human prostate cancer patients
(Elsevier, 2022)
Background: The purpose of the present study was to perform a high-resolution melting (HRM) analysis to discover mutations in gene exons 5-8 of tumor protein p53 (TP53), as well as the relationships of these mutations to ...